Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of LGD-6972 in healthy subjects and individuals with Type 2 Diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LGD-6972

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED